Everts, P.A.; Mazzola, T.; Mautner, K.; Randelli, P.S.; Podesta, L.
Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies. Biomedicines 2022, 10, 2933.
https://doi.org/10.3390/biomedicines10112933
AMA Style
Everts PA, Mazzola T, Mautner K, Randelli PS, Podesta L.
Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies. Biomedicines. 2022; 10(11):2933.
https://doi.org/10.3390/biomedicines10112933
Chicago/Turabian Style
Everts, Peter A., Timothy Mazzola, Kenneth Mautner, Pietro S. Randelli, and Luga Podesta.
2022. "Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies" Biomedicines 10, no. 11: 2933.
https://doi.org/10.3390/biomedicines10112933
APA Style
Everts, P. A., Mazzola, T., Mautner, K., Randelli, P. S., & Podesta, L.
(2022). Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies. Biomedicines, 10(11), 2933.
https://doi.org/10.3390/biomedicines10112933